Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 128 clinical trials
Featured trial
An investigational research study designed to confirm therapeutic equivalence of study inhaler to an inhaled product currently on the market for the treatment of asthma. 3-4 visits in this study. Compensation for participation for those who qualify.

This asthma research study involves 3-4 visits and should complete in about 6 weeks. Morning appointments required and can be done Monday-Saturday.  Visits are two hours or less. Compensation for participation is provided to those who qualify.  

  • 116 views
  • 23 Nov, 2020
  • 1 location
Featured trial
COPD Research Study for those with currently using inhaled medications (triple therapy) and have required an oral steroid for a flare in breathing 1-2 times in the last 12 months.

This investigational study is enrolling moderate to severe COPD subjects.   To qualify you must be on inhaled maintenance medications and have required oral steroids 1-2 times or a hospitalization in the last year.    Pulmonary function test will be performed and compensation will be provided for those who qualify.  

  • 147 views
  • 23 Nov, 2020
  • 1 location
Featured trial
  • 5 views
  • 28 Jun, 2022
  • 1 location
Featured trial
A 26 week, randomized, active-controlled safety study of a double-blind formoterol fumarate in free combination with an inhaled corticosteroid versus and inhaled corticosteroid in adolescent and adult patients with persistent asthma.

A 26 week, randomized, active-controlled safety study of a double-blind formoterol fumarate in free combination with an inhaled corticosteroid versus and inhaled corticosteroid in adolescent and adult patients with persistent asthma.

  • 254 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Phase III, randomized, double-blind, active-controlled, parallel-group study, comparing the efficacy, safety and tolerability of the fixed dose combination of FF/UMEC/VI with the fixed dose dual combination of FF/VI, administered once-daily via a dry powder inhaler in subjects with inadequately controlled ASTHMA.

Phase III, randomized, double-blind, active-controlled, parallel-group study, comparing the efficacy, safety and tolerability of the fixed dose combination of FF/UMEC/VI with the fixed dose dual combination of FF/VI, administered once-daily via a dry powder inhaler in subjects with inadequately controlled ASTHMA.

  • 434 views
  • 23 Nov, 2020
  • 1 location
Inhaled Heparin for Hospitalised COVID-19 Patients (INHALE-HEP)

This meta-trial is a prospective collaborative individual participant data meta-analysis of randomised controlled trials and early phase studies. Individual studies will be conducted in multiple countries, including Australia, the UK, the USA, Ireland, Argentina, Brazil and Egypt. Adult patients admitted to the hospital with confirmed SARS-CoV-2 infection, who do not …

  • 5 views
  • 25 Mar, 2022
  • 2 locations
A Randomised Active-controlled Study to Compare Efficacy & Safety of Inhaled Isoflurane Delivered by the AnaConDa-S (Anaesthetic Conserving Device) vs IV Midazolam for Sedation in Mechanically Ventilated Paediatric Patients 3-17 Years Old (IsoCOMFORT)

This is a study to compare safety and efficacy of inhaled isoflurane delivered by the AnaConDa-S versus intravenous midazolam for sedation in mechanically ventilated children admitted to an intensive care unit.

  • 0 views
  • 17 Sep, 2022
  • 16 locations
A Phase 2b, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension

The main objective of the study is to assess the effect of treprostinil palmitil inhalation powder (TPIP) compared with placebo on pulmonary vascular resistance.

  • 5 views
  • 21 Sep, 2022
  • 25 locations
An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Oral Inhalation of GB002 for the Treatment of WHO Group 1 Pulmonary Arterial Hypertension (PAH)

This open-label extension study will evaluate the long-term effects of GB002 (seralutinib) in subjects who previously participated in a GB002 PAH study.

  • 0 views
  • 16 Sep, 2022
  • 22 locations
A 12-week Randomized, participant-and Investigator-blinded, Placebo-controlled, Parallel Group Study to Explore the Efficacy, Pharmacodynamics, Safety, and Pharmacokinetics of Two Doses of Inhaled CSJ117 in Adults With Chronic Obstructive Pulmonary Disease (COPD)

This is a Phase 2 study in patients with chronic obstructive pulmonary disease (COPD) to assess the efficacy, pharmacodynamics (PD), pharmacokinetics (PK), and safety of two dose levels of CSJ117 in comparison to placebo. For this, the impact of CSJ117 on disease symptom burden and lung function will be explored.

  • 6 views
  • 17 Sep, 2022
  • 28 locations